Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 9.34 USD -1.16% Market Closed
Market Cap: 638.7m USD
Have any thoughts about
Phathom Pharmaceuticals Inc?
Write Note

Income Statement

Earnings Waterfall
Phathom Pharmaceuticals Inc

Revenue
26.3m USD
Cost of Revenue
-4.3m USD
Gross Profit
21.9m USD
Operating Expenses
-309.9m USD
Operating Income
-287.9m USD
Other Expenses
-51.5m USD
Net Income
-339.4m USD

Income Statement
Phathom Pharmaceuticals Inc

Rotate your device to view
Income Statement
Currency: USD
Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
1
N/A
3
+280%
10
+282%
26
+165%
Gross Profit
Cost of Revenue
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(1)
(2)
(4)
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
1
N/A
2
+289%
8
+297%
22
+176%
Operating Income
Operating Expenses
(85)
(91)
(106)
(125)
(62)
(89)
(126)
(139)
(154)
(154)
(135)
(141)
(151)
(159)
(172)
(165)
(151)
(144)
(168)
(209)
(261)
(310)
Selling, General & Administrative
(3)
(4)
(7)
(11)
(14)
(20)
(28)
(36)
(45)
(54)
(63)
(70)
(83)
(90)
(101)
(99)
(92)
(92)
(118)
(161)
(218)
(271)
Research & Development
(82)
(87)
(99)
(115)
(48)
(69)
(98)
(103)
(110)
(100)
(72)
(69)
(67)
(69)
(71)
(65)
(59)
(52)
(50)
(48)
(42)
(39)
Operating Income
(85)
N/A
(91)
-7%
(106)
-17%
(125)
-18%
(62)
+50%
(89)
-43%
(126)
-41%
(139)
-11%
(154)
-11%
(154)
0%
(135)
+13%
(141)
-5%
(151)
-7%
(159)
-5%
(172)
-9%
(165)
+5%
(151)
+8%
(144)
+5%
(167)
-16%
(207)
-24%
(253)
-22%
(288)
-14%
Pre-Tax Income
Interest Income Expense
(1)
(3)
(3)
(3)
(3)
(3)
(3)
(5)
(5)
(5)
(7)
(8)
(13)
(20)
(25)
(30)
(34)
(33)
(34)
(39)
(44)
(51)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
(2)
(2)
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
(4)
(64)
(146)
(146)
(142)
(82)
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Pre-Tax Income
(90)
N/A
(158)
-76%
(255)
-62%
(274)
-7%
(207)
+24%
(173)
+16%
(129)
+26%
(144)
-11%
(159)
-11%
(162)
-2%
(144)
+11%
(150)
-4%
(164)
-10%
(179)
-9%
(198)
-11%
(195)
+1%
(185)
+5%
(177)
+4%
(202)
-14%
(247)
-22%
(297)
-20%
(339)
-14%
Net Income
Income from Continuing Operations
(90)
(158)
(255)
(274)
(207)
(173)
(129)
(144)
(159)
(162)
(144)
(150)
(164)
(179)
(198)
(195)
(185)
(177)
(202)
(247)
(297)
(339)
Net Income (Common)
(90)
N/A
(158)
-76%
(255)
-62%
(274)
-7%
(207)
+24%
(173)
+16%
(129)
+26%
(144)
-11%
(159)
-11%
(162)
-2%
(144)
+11%
(150)
-4%
(164)
-10%
(179)
-9%
(198)
-11%
(195)
+1%
(185)
+5%
(177)
+4%
(202)
-14%
(247)
-22%
(297)
-20%
(339)
-14%
EPS (Diluted)
-3.47
N/A
-6.42
-85%
-10.32
-61%
-10.89
-6%
-8.09
+26%
-6.68
+17%
-3.88
+42%
-4.97
-28%
-5.45
-10%
-5.38
+1%
-4.72
+12%
-3.93
+17%
-4.28
-9%
-4.59
-7%
-5.05
-10%
-4.6
+9%
-3.81
+17%
-3.11
+18%
-3.93
-26%
-4.22
-7%
-5.07
-20%
-5.25
-4%

See Also

Discover More